Nucleoside Analogue Reverse Transcriptase Inhibitors Differentially Inhibit Human LINE-1 Retrotransposition
Open accessThe DOI matches its Crossref record; 41 of the 42 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Intact LINE-1 elements are the only retrotransposons encoded by the human genome known to be capable of autonomous replication. Numerous cases of genetic disease have been traced to gene disruptions caused by LINE-1 retrotransposition events in germ-line cells. In addition, genomic instability resulting from LINE-1 retrotransposition in somatic cells has been proposed as a contributing factor to oncogenesis and to cancer progression. LINE-1 element activity may also play a role in normal physiology. METHODS AND PRINCIPAL FINDINGS: Using an in vitro LINE-1 retrotransposition reporter assay, we evaluated the abilities of several antiretroviral compounds to inhibit LINE-1 retrotransposition. The nucleoside analogue reverse transcriptase inhibitors (nRTIs): stavudine, zidovudine, tenofovir disoproxil fumarate, and lamivudine all inhibited LINE-1 retrotransposition with varying degrees of potencies, while the non-nucleoside HIV-1 reverse transcriptase inhibitor nevirapine showed no effect. CONCLUSIONS/SIGNIFICANCE: Our data demonstrates the ability for nRTIs to suppress LINE-1 retrotransposition. This is immediately applicable to studies aimed at examining potential roles for LINE-1 retrotransposition in physiological processes. In addition, our data raises novel safety considerations for nRTIs based on their potential to disrupt physiological processes involving LINE-1 retrotransposition.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“One study demonstrated by using an in vitro LINE-1 retrotransposition assay that L1 retrotransposition could be suppressed by a number of different NRTIs with different degrees of potencies (Jones et al., 2008).”
From Cytoplasmic DNA: sources, sensing, and role in aging and disease (2021) · cites this paper as Jones et al., 2008
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Roman-Gomez, J., Jimenez-Velasco, A., Agirre, X., Cervantes, F., Sanchez, J., Garate, L., Barrios, M., Castillejo, J. A., Navarro, G., Colomer, D., et al. (2005) · Oncogene · doi:10.1038/sj.onc.1208866 · Cited by 215
RetractedInitial sequencing and analysis of the human genome
International Human Genome Sequencing Consortium, Whitehead Institute for Biomedical Research, C. F. G. R., Lander, E. S., Linton, L. M., Birren, B., Nusbaum, C., Zody, M. C., Baldwin, J., Devon, K., Dewar, K., et al. (2001) · Nature · doi:10.1038/35057062 · Cited by 24,216 · cited 1×
“genome sequencing project was the observation that our genome is 42% comprised of retrotransposable element (RE) sequence [1].”
Mitsuya, H., Weinhold, K. J., Furman, P. A., St Clair, M. H., Lehrman, S. N., Gallo, R. C., Bolognesi, D., Barry, D. W., & Broder, S. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.20.7096 · Cited by 1,866
Human L1 retrotransposon encodes a conserved endonuclease required for retrotransposition
Feng, Q., Moran, J. V., Kazazian, H. H., & Boeke, J. D. (1996) · Cell · doi:10.1016/s0092-8674(00)81997-2 · Cited by 1,139
Hot L1s account for the bulk of retrotransposition in the human population
Brouha, B., Schustak, J., Badge, R. M., Lutz-Prigge, S., Farley, A. H., Moran, J. V., & Kazazian, H. H. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0831042100 · Cited by 1,073 · cited 3×
“‘hot’ LINE-1 elements, and demonstrated that a high degree of similarity of a LINE-1 sequence to this consensus is predictive of high-level in vitro activity [3].”
BackgroundHigh frequency retrotransposition in cultured mammalian cells
Moran, J. V., Holmes, S. E., Naas, T. P., DeBerardinis, R. J., Boeke, J. D., & Kazazian, H. H. (1996) · Cell · doi:10.1016/s0092-8674(00)81998-4 · Cited by 1,022
Somatic mosaicism in neuronal precursor cells mediated by L1 retrotransposition
Muotri, A. R., Chu, V. T., Marchetto, M. C. N., Deng, W., Moran, J. V., & Gage, F. H. (2005) · Nature · doi:10.1038/nature03663 · Cited by 942 · cited 2×
“LINE-1 retrotransposition has been implicated in the generation of somatic mosaicism of neurons, and other cells over the course of development [25].”
BackgroundKazazian, H. H., Wong, C., Youssoufian, H., Scott, A. F., Phillips, D. G., & Antonarakis, S. E. (1988) · Nature · doi:10.1038/332164a0 · Cited by 929
Disruption of the APC gene by a retrotransposal insertion of L1 sequence in a colon cancer.
Miki, Y., Nishisho, I., Horii, A., Miyoshi, Y., Utsunomiya, J., Kinzler, K. W., Vogelstein, B., & Nakamura, Y. (1992) · PubMed · Cited by 564
Sequence patterns indicate an enzymatic involvement in integration of mammalian retroposons
Jurka, J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.5.1872 · Cited by 556
Mechanism of Inhibition of HIV-1 Reverse Transcriptase by Nonnucleoside Inhibitors
Spence, R. A., Kati, W. M., Anderson, K. S., & Johnson, K. A. (1995) · Science · doi:10.1126/science.7532321 · Cited by 522
Human L1 element target‐primed reverse transcription in vitro
Cost, G. J., Feng, Q., Jacquier, A., & Boeke, J. D. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf592 · Cited by 519
Many human L1 elements are capable of retrotransposition
Sassaman, D. M., Dombroski, B. A., Moran, J. V., Kimberland, M. L., Naas, T. P., DeBerardinis, R. J., Gabriel, A., Swergold, G. D., & Kazazian, H. H. (1997) · Nature Genetics · doi:10.1038/ng0597-37 · Cited by 451
Nucleic Acid Chaperone Activity of the ORF1 Protein from the Mouse LINE-1 Retrotransposon
Martin, S. L., & Bushman, F. D. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.2.467-475.2001 · Cited by 348
Smerdon, S. J., Jäger, J., Wang, J., Kohlstaedt, L. A., Chirino, A. J., Friedman, J. M., Rice, P. A., & Steitz, T. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.9.3911 · Cited by 331
Determination of L1 retrotransposition kinetics in cultured cells
Ostertag, E. M. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.6.1418 · Cited by 291 · cited 2×
“This system is described in detail elsewhere, and portrayed in Figure 1A [29].”
MethodBarret, B., Tardieu, M., Rustin, P., Lacroix, C., Chabrol, B., Desguerre, I., Dollfus, C., Mayaux, M.-J., & Blanche, S. (2003) · AIDS · doi:10.1097/00002030-200308150-00006 · Cited by 281
Molecular archeology of L1 insertions in the human genome
Szak, S. T., Pickeral, O. K., Makalowski, W., Boguski, M. S., Landsman, D., & Boeke, J. D. (2002) · Genome Biology · doi:10.1186/gb-2002-3-10-research0052 · Cited by 230
Narita, N., Nishio, H., Kitoh, Y., Ishikawa, Y., Ishikawa, Y., Minami, R., Nakamura, H., & Matsuo, M. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116402 · Cited by 207
L1 retrotransposition can occur early in human embryonic development
van den Hurk, J. A. J. M., Meij, I. C., del Carmen Seleme, M., Kano, H., Nikopoulos, K., Hoefsloot, L. H., Sistermans, E. A., de Wijs, I. J., Mukhopadhyay, A., Plomp, A. S., et al. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm108 · Cited by 193 · cited 1×
“In addition, ‘hot’ LINE-1 elements are the progenitors for the majority of disease-causing insertional events isolated ex vivo [18].”
BackgroundSequence-specific single-strand RNA binding protein encoded by the human LINE-1 retrotransposon
Hohjoh, H., & Singer, M. F. (1997) · The EMBO Journal · doi:10.1093/emboj/16.19.6034 · Cited by 189
L1 retrotransposition in nondividing and primary human somatic cells
Kubo, S., Seleme, M. D. C., Soifer, H. S., Perez, J. L. G., Moran, J. V., Kazazian, H. H., & Kasahara, N. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601954103 · Cited by 181
LINE-1 Retrotransposition Requires the Nucleic Acid Chaperone Activity of the ORF1 Protein
Martin, S. L., Cruceanu, M., Branciforte, D., Wai-lun Li, P., Kwok, S. C., Hodges, R. S., & Williams, M. C. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.03.003 · Cited by 177
Kolosha, V. O., & Martin, S. L. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.19.10155 · Cited by 167
The ORF1 Protein Encoded by LINE‐1: Structure and Function During L1 Retrotransposition
Martin, S. L. (2006) · BioMed Research International · doi:10.1155/jbb/2006/45621 · Cited by 142
Trimeric structure for an essential protein in L1 retrotransposition
Martin, S. L., Branciforte, D., Keller, D., & Bain, D. L. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2336221100 · Cited by 132
Mangiacasale, R., Pittoggi, C., Sciamanna, I., Careddu, A., Mattei, E., Lorenzini, R., Travaglini, L., Landriscina, M., Barone, C. A., Nervi, C., et al. (2003) · Oncogene · doi:10.1038/sj.onc.1206354 · Cited by 126
Meischl, C., de Boer, M., Åhlin, A., & Roos, D. (2000) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5200523 · Cited by 123
Chappuy, H., Tréluyer, J.-M., Jullien, V., Dimet, J., Rey, E., Fouché, M., Firtion, G., Pons, G., & Mandelbrot, L. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.11.4332-4336.2004 · Cited by 97
Martin, S. L., Li, J., & Weisz, J. A. (2000) · Journal of Molecular Biology · doi:10.1006/jmbi.2000.4182 · Cited by 91
Spatial Assembly and RNA Binding Stoichiometry of a LINE-1 Protein Essential for Retrotransposition
Basame, S. B., Li, P. W.-L., Howard, G., Branciforte, D., Keller, D., & Martin, S. L. (2006) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.12.063 · Cited by 91
An indicator gene to demonstrate intracellular transposition of defective retroviruses.
Heidmann, T., Heidmann, O., & Nicolas, J. F. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.7.2219 · Cited by 90
Mandelbrot, L., Peytavin, G., Firtion, G., & Farinotti, R. (2001) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2001.108344 · Cited by 63
Cherry, C. L., Nolan, D., James, I. R., McKinnon, E. J., Mallal, S. A., Gahan, M. E., Lal, L., McArthur, J. C., & Wesselingh, S. L. (2006) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/01.qai.0000224974.67962.ce · Cited by 56
The maternal-fetal transfer of lamivudine in the ex vivo human placenta
Bloom, S. L., Dias, K. M., Bawdon, R. E., & Gilstrap, L. C. (1997) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(97)70487-3 · Cited by 42
The ex vivo Transfer of the Anti-HIV Nucleoside Compound d4T in the Human Placenta
Bawdon, R. E., Kaul, S., & Sobhi, S. (2010) · Gynecologic and Obstetric Investigation · doi:10.1159/000292432 · Cited by 38
Mušová, Z., Hedvičáková, P., Mohrmann, M., Tesařová, M., Křepelová, A., Zeman, J., & Sedláček, Z. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.06.071 · Cited by 33
Xie, H. J., Voronkov, M. V., Liotta, D. C., Korba, B. A., Schinazi, R. F., Richman, D. D., & Hostetler, K. Y. (1995) · Antiviral Research · doi:10.1016/0166-3542(95)00042-k · Cited by 24
Albina, M. L., Bell�s, M., Sánchez, D. J., & Domingo, J. L. (2000) · Teratology · doi:10.1002/1096-9926(200008)62:2<93::aid-tera5>3.0.co;2-m · Cited by 23
Drew, R. H., Weller, S., Gallis, H. A., Walmer, K. A., Bartlett, J. A., & Blum, M. R. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.10.1801 · Cited by 16
Lamivudine useful against hepatitis B-HIV co-infection.
Lm, P. (1995) · PubMed · Cited by 4
Cited by
Retrotransposons Revisited: The Restraint and Rehabilitation of Parasites
Goodier, J. L., & Kazazian, H. H. (2008) · Cell · doi:10.1016/j.cell.2008.09.022 · Cited by 626
“Also, a recent study reported inhibition of L1 retrotransposition in cell culture by nucleoside analog reverse transcriptase inhibitors but not by nevirapine (Jones et al., 2008).”
A LINE1-Nucleolin Partnership Regulates Early Development and ESC Identity
Percharde, M., Lin, C.-J., Yin, Y., Guan, J., Peixoto, G. A., Bulut-Karslioglu, A., Biechele, S., Huang, B., Shen, X., & Ramalho-Santos, M. (2018) · Cell · doi:10.1016/j.cell.2018.05.043 · Cited by 555
“Inhibition of LINE1 retrotransposition using antiretroviral drugs (Jones et al., 2008) does not phenocopy LINE1 RNA KD, indicating that its role in ESCs is independent of retrotransposition (Figures S2G–S2I).”
InfluentialLINE1 Derepression in aged wild-type and SIRT6-deficient mice drives inflammation
Simon, M., Van Meter, M., Ablaeva, J., Ke, Z., Gonzalez, R. S., Taguchi, T., De Cecco, M., Leonova, K. I., Kogan, V., Helfand, S. L., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.02.014 · Cited by 498
“Several studies have reported that in addition to impeding the activity of viral polymerases, NRTIs such as 3TC and d4T, are also potent inhibitors of L1 RT (Dai et al., 2011; Jones et al., 2008).”
BackgroundThe quest to slow ageing through drug discovery
Partridge, L., Fuentealba, M., & Kennedy, B. K. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0067-7 · Cited by 468
Thomas, C. A., Tejwani, L., Trujillo, C. A., Negraes, P. D., Herai, R. H., Mesci, P., Macia, A., Crow, Y. J., & Muotri, A. R. (2017) · Cell Stem Cell · doi:10.1016/j.stem.2017.07.009 · Cited by 330
“These inhibitors are well known anti-HIV-1 drugs that have been shown to inhibit both HIV and L1 reverse transcription (Jones et al., 2008).”
Background
Metadata
- Authors
- Jones, R. B., Garrison, K. E., Wong, J. C., Duan, E. H., Nixon, D. F., & Ostrowski, M. A.
- Affiliations
- University of Toronto (CA)
- University of California, San Francisco (US)
- St. Michael's Hospital (CA)
- Corresponding author
- Jones, R. Brad
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2008-02-06
- Volume
- 3
- Issue
- 2
- Pages
- e1547
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC2212136
- OpenAlex
- W2002118607
- Cited by
- 99
- References
- 42
- Citations by year
- 2026: 7 · 2025: 7 · 2024: 9 · 2023: 6 · 2022: 6 · 2021: 7 · 2020: 12 · 2019: 5 · 2018: 5 · 2017: 5 · 2016: 3 · 2015: 1 · 2014: 4 · 2013: 8 · 2012: 2
- FWCI
- 4.85
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Pfizer
- Ontario Innovation Trust
- Canadian Foundation for AIDS Research
- Ontario HIV Treatment Network
- National Institutes of Health
- University of California, San Francisco
- Canadian Institutes of Health Research
- National Institute of Allergy and Infectious Diseases
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Chromosomal and Genetic Variations
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Keywords
- LINE-1 retrotransposition, retrotransposons, antiretroviral drugs, stavudine, zidovudine, tenofovir disoproxil fumarate, lamivudine, nevirapine, drug safety, genomic instability, carcinogenesis
- MeSH terms
- Drug Evaluation, Humans, Nucleosides, Genome, Human, Retroelements, Reverse Transcriptase Inhibitors, Long Interspersed Nucleotide Elements, Drug-Related Side Effects and Adverse Reactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.